cipients of organ transplants who receive therapeutic immunosuppression. Such an increase in neoplasms, however, is not seen in RA patients. The control of early lymphoblastoid cell outgrowth is mediated by mononuclear cells with natural killer (NK) like properties and interferon.3 4 The later control of EBV induced immunoglobulin secretion and the lysis of EBV infected cells is mediated by suppressor and cytotoxic T lymphocytes respectively.97 In order for a chronic EBV infection to occur which would result in persistent polyclonal B cell activation it would be logical to suggest that RA patients lack the ability to generate EBV specific cytotoxic T lymphocytes (CTLs). It has been reported, however, that RA patients do not have an 546 impairment in their ability to generate EBV specific CTLs. 7 The purpose of the present report was to reexamine whether there are defects in several cytotoxic mechanisms which could control EBV infection in RA patients.In contrast with the report mentioned above we A standard four hour chromium release assay was used as previously described.1 Cells from log phase cultures of K562 and the LCLs were labelled with chromium-51 sodium chromate, specific activity 200-500 Ci/g chromium (New England Nuclear, Boston, MA) for one and six hours respectively. Target cells at 1 x 105/ml, and unfractionated PBMC at 5x106/ml were suspended in RPMI 1640 supplemented with 10% fetal bovine serum and plated in round bottomed microtitre Linbro plates in a final volume of 0*2 ml. The plates were incubated for four hours in a 5% CO2 incubator at 37°C. 0-1 ml of supernatant was aspirated from the top of the wells, and the radioactivity released was counted in a Packard A 800 C gammacounter. Control counts for spontaneous release were obtained from wells containing only target cells.
Maximal release was determined with labelled target cells lysed with detergent. Specific Table 3 . IL-2 in culture augmented lysis of K562 cells and expanded the target cell repertoire to NK resistant, EBV infected LCLs. When the immune and non-immune normal donors were compared no antigen specificity or HL-A restriction in LCL target lysis was found ( Table 3 ). The PBMC from RA patients were able to generate cytotoxicity against EBV infected LCLs at a level comparable with that of the normal donors (Table 3) . Data from the five experiments are shown in Fig. 1 
